Chloroquine and Artemisia Annua: the new coronavirus remedies?

Teny Malagasy Français DeutschEspanolItaliano 中国人

Artemisia Annua Madagascar

Currently two cures for Covid-19 are the focus of attention. One, chloroquine, is a drug already used to fight malaria, and the other, artemisia annua, a medicinal plant with multiple virtues. In this article, we reveal the benefits and potentialities of these two potential remedies against Covid-19.

 

Chloroquine: what effect on Covid-19?

When the epidemic was in full swing in China, Chinese researchers had already thought of the chloroquine trail. They conducted a clinical trial on 100 patients in about ten hospitals across the country. The results were quite reassuring since the drug could contain the progression of pneumonia and improve the condition of the lungs. Chloroquine could also shorten the lifespan of the virus and thus allow the patient to quickly obtain a negative test result. A study carried out in France by Pr Didier Raoult confirmed the effectiveness of this drug in treating cases of Covid-19.

At the beginning of April 2020, Pr Raoult conducted a clinical study on more than 1000 patients. He administered hydroxychloroquine and azithromycin to them. After 10 days of treatment, recovery was observed in 91.7% of patients. At the same time, 5 elderly patients died and 10 others were placed in intensive care, and about 30 patients had to be hospitalized. These results are encouraging, and to further refine the course of action, other clinical trials incorporating chloroquine as a treatment to be administered are underway in Europe and America.

Artemisia Annua: another potential cure for Covid-19?

Artemisia Annua is a plant that has been used for millennia in China. It is highly appreciated for its active ingredients, particularly artemisinin. This molecule is also at the origin of many antimalarial drugs currently in use. When forms of resistance to chloroquine appeared, artemisinin-based combination therapies were introduced.

This plant contains quercetin and luteolin as well as many compounds with recognized immunomodulatory activity. It was thus used to fight against the first coronavirus which occurred in China in 2003. There is thus a strong chance that this plant will be used to control Covid-19.

On 8 April 2020, the Postsdam Colloid Research Institute, Max Planck set up a cellular study to test the effects of artemisia annua on the virus responsible for covid-19. This was made possible through collaboration with the American company ArtemiLife, which grows and markets herbal teas based on this plant.

In Madagascar, in April 2020, the Institut Malgache de Recherches Appliquées (IMRA), which specializes in the development of remedies based on medicinal plants, has developed a remedy against Covid-19 based on artemisia annua: covic organics. Convincing results have already been seen in patients who have consented to take it.

 

All information provided on the website www.covid-organics.com is for informational purposes only. They do not engage our responsibility because this information does not substitute in any case the opinion of a doctor. For any use of the products offered on this site (essential oils and others) for therapeutic purposes, please consult a medical professional.